相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
Naveena Singh et al.
JOURNAL OF PATHOLOGY (2020)
Reclassifying endometrial carcinomas with a combined morphological and molecular approach
Joseph Carlson et al.
CURRENT OPINION IN ONCOLOGY (2019)
CyclinD1, a prominent prognostic marker for endometrial diseases
Shuo Liang et al.
DIAGNOSTIC PATHOLOGY (2013)
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
Gian Franco Zannoni et al.
HUMAN PATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma (vol 497, pg 67, 2013)
Gad Getz
NATURE (2013)
Molecular Profile of Grade 3 Endometrioid Endometrial Carcinoma: Is it a Type I or Type II Endometrial Carcinoma?
Teresa Alvarez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study
Gian Franco Zannoni et al.
VIRCHOWS ARCHIV (2010)
Molecular Profiling of Endometrial Malignancies
Norasate Samarnthai et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2010)
Novel molecular profiles of endometrial cancer - new light through old windows
A. Doll et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
p53 and BCL-2 as prognostic markers in endometrial carcinoma
Marcia L. M. Appel et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Prognostic significance of oestrogen receptor alpha (ERα) and beta (ERβ), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas
Naim Shabani et al.
EUROPEAN JOURNAL OF CANCER (2007)
Biological roles of estrogen and progesterone in human endometrial carcinoma - New developments in potential endocrine therapy for endometrial cancer
Kiyoshi Ito et al.
ENDOCRINE JOURNAL (2007)
Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: Similar outcomes belie distinctive biologic differences
Robert A. Soslow et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification
SF Lax
VIRCHOWS ARCHIV (2004)
Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer
LK Mell et al.
CLINICAL CANCER RESEARCH (2004)
Cyclin D1 gene (CCND1) mutations in endometrial cancer
G Moreno-Bueno et al.
ONCOGENE (2003)
β-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype
PW Schlosshauer et al.
MODERN PATHOLOGY (2002)
Rho protein inactivation induced apoptosis of cultured human endothelial cells
S Hippenstiel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
分享论文
